stoxline Quote Chart Rank Option Currency Glossary
  
Inogen, Inc. (INGN)
6.64  0.04 (0.61%)    06-20 16:00
Open: 6.69
High: 6.73
Volume: 302,889
  
Pre. Close: 6.6
Low: 6.595
Market Cap: 179(M)
Technical analysis
2025-06-20 4:41:26 PM
Short term     
Mid term     
Targets 6-month :  8.29 1-year :  9.68
Resists First :  7.09 Second :  8.29
Pivot price 6.48
Supports First :  6.23 Second :  5.69
MAs MA(5) :  6.51 MA(20) :  6.5
MA(100) :  7.75 MA(250) :  9.03
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  42.9 D(3) :  37.1
RSI RSI(14): 52.7
52-week High :  13.32 Low :  5.69
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ INGN ] has closed below upper band by 17.7%. Bollinger Bands are 71.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 6.74 - 6.77 6.77 - 6.79
Low: 6.53 - 6.56 6.56 - 6.59
Close: 6.59 - 6.64 6.64 - 6.68
Company Description

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Headline News

Mon, 16 Jun 2025
Inogen (INGN) Stock Coverage Initiated by B. Riley Securities | INGN Stock News - GuruFocus

Mon, 16 Jun 2025
Inogen: Still Breathing, But Margin Pressures Persist (NASDAQ:INGN) - Seeking Alpha

Mon, 16 Jun 2025
Inogen (INGN) Initiated with Buy Rating by B. Riley Analyst | INGN Stock News - GuruFocus

Tue, 10 Jun 2025
Here’s Why Brown Capital Management Small Company Fund Sold Inogen (INGN) in Q1 - Insider Monkey

Thu, 22 May 2025
Needham Upgrades Inogen (INGN) to Buy - MSN

Thu, 22 May 2025
Needham Upgrades Inogen (INGN) - Nasdaq

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 27 (M)
Shares Float 24 (M)
Held by Insiders 12.1 (%)
Held by Institutions 73.9 (%)
Shares Short 1,100 (K)
Shares Short P.Month 911 (K)
Stock Financials
EPS -1.15
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.36
Profit Margin -8.1 %
Operating Margin -9.4 %
Return on Assets (ttm) -6.2 %
Return on Equity (ttm) -14.2 %
Qtrly Rev. Growth 5.5 %
Gross Profit (p.s.) 5.82
Sales Per Share 12.64
EBITDA (p.s.) -0.38
Qtrly Earnings Growth 0 %
Operating Cash Flow -6 (M)
Levered Free Cash Flow -17 (M)
Stock Valuations
PE Ratio -5.78
PEG Ratio 0
Price to Book value 0.9
Price to Sales 0.52
Price to Cash Flow -29.13
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android